Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors), SIRT2 inhibitors(sirtuin 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC38H45N9O5S2 |
InChIKeyVNFKTHQLIBPFNF-UHFFFAOYSA-N |
CAS Registry3032670-12-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | DE | 09 Nov 2023 |